Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
Clinical trial NCT03547973 · RECRUITING
Trial details
- NCT number
- NCT03547973
- Sponsor
- Gilead Sciences
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-13
- Primary completion
- 2030-04-01
- Enrollment
- 827
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.